Figure 3

PFS and OS among all patients ((a) and (b)) and PFS and OS in patients with favorable prognosis (GTR, MGMT-methylation) ((c) and (d)) are compared according to inclusion of peritumoral edema in the radiotherapy target volume.
PFS and OS among all patients ((a) and (b)) and PFS and OS in patients with favorable prognosis (GTR, MGMT-methylation) ((c) and (d)) are compared according to inclusion of peritumoral edema in the radiotherapy target volume.